Adicet Bio, Inc. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
Adicet Bio, Inc. (ACET) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $5.73 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-12
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2025 was $5.73M, a 27.49% decline from fiscal 2024.
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2024 was $7.91M, a 9.08% decline from fiscal 2023.
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2023 was $8.70M, a 52.04% increase from fiscal 2022.
- Adicet Bio, Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2022 was $5.72M, a 76.41% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $5.73M 10-K · filed 2026-03-12 |
| 2024-12-31 | $7.91M 10-K · filed 2026-03-12 |
| 2023-12-31 | $8.70M 10-K · filed 2025-03-06 |
| 2022-12-31 | $5.72M 10-K · filed 2024-03-19 |
| 2021-12-31 | $3.24M 10-K · filed 2023-03-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |